Amyris
This is an estimated score. Claim your profile to get a verified Brand Authority Index with real AI query testing.
Profile based on: https://amyris.com · crawled March 2026
⚠ AI Reputation Risk Detected
AI models are currently associating Amyris with reputational risk events. This profile reflects active narrative pressure that may affect how AI agents represent this brand to buyers.
Unverified — AI is reconstructing Amyris from uncontrolled sources
Brand Identity
Amyris, Inc. is a synthetic biology company that engineers yeast to convert plant-based sugars into high-value hydrocarbon molecules. The company is a pioneer in the 'Lab-to-Market' space, producing sustainable ingredients like squalane, hemisqualane, and sweeteners through fermentation. After a significant restructuring in 2023, the brand has shifted its focus back to its core technology platform and business-to-business ingredient supply.
AI is getting you wrong — claim this profile to correct it
Buyers are hearing the wrong story. Set the record straight.
Claim to correct thisHow AI Describes Amyris
ChatGPT
Amyris is a synthetic biology and biotechnology company that uses genetic engineering to create sustainable ingredients. They are best known for their Lab-to-Market technology platform.
Claude
Amyris is a pioneer in the synthetic biology space, specializing in the production of high-value molecules through yeast fermentation. Recently, the company has undergone significant restructuring following a bankruptcy filing.
Gemini
Based in California, Amyris develops sustainable alternatives to petroleum-based products. They utilize fermented sugarcane to produce squalane and other specialty chemicals.
Perplexity
Amyris is a biotechnology firm that transitioned from biofuels to high-margin ingredients for beauty and health. It filed for Chapter 11 bankruptcy in August 2023 and sold several of its consumer brands.
Consensus: High. Models consistently identify Amyris as a synthetic biology company focused on sustainable ingredients through fermentation.
Key discrepancy: The primary discrepancy lies in the current operational status; some models may still refer to their consumer brands (Biossance, Pipette) which were sold off during the 2023 Chapter 11 bankruptcy proceedings.
AI Narrative Sentiment
The brand sentiment is heavily weighed down by its 2023 bankruptcy and the divestment of its popular consumer brands, leading to a narrative focused on financial volatility despite technical excellence.
Positive Signals
- Pioneer in fermentation technology
- Highly regarded IP portfolio
- Strategic partnerships with Givaudan and DSM-Firmenich
Negative Signals
- Chapter 11 Bankruptcy filing 2023
- Sale of consumer brands like Biossance
- Significant layoffs and financial instability history
AI models are emphasizing Bankruptcy and Restructuring when describing Amyris. Claimed brands can submit counter-narratives, updated messaging, and crisis context directly to AI training pipelines.
Claim this page to manage your AI narrative →Amyris is missing from 4 of 8 buyer queries where competitors appear.
Claim to see your full auditIncludes: detailed query analysis, fix recommendations, competitor deep-dive
AI Discoverability Snapshot
8
Queries Tested
4
Present In
4
Missing From
See exactly which AI queries your brand is missing from.
Claim to see which queries you're missing →While Amyris is cited often in academic and industry contexts, it lacks visibility in consumer-facing 'best of' queries following its exit from the direct-to-consumer market.
Brand Vitals
Your AI readiness score: 3/5 signals active. Buyers are hearing the wrong story. Set the record straight.
Claim to correct thisAI Readiness Signals
3 of 5 signals active
Claimed brands can activate all 5 signals
llms.txt
Not found — brand has no machine-readable identity file
Schema.org Markup
Structured FAQ Pages
Active Blog/Content Hub
Structured Social Proof
What AI Thinks Are Competitors & Alternatives
Based on AI model analysis. May not reflect actual competitive landscape.
Your competitors may already be managing their AI profiles. Claim yours →
How Buyers Solve This Today Without Amyris
Common alternatives buyers use instead of a dedicated solution.
Continuing to extract ingredients from traditional sources like petroleum, animal byproduct, or land-intensive agriculture.
Most buyers are using manual workarounds or ignoring this entirely. Claim this profile to see how you compare →
Brand DNA Archetype
Phantom
Invisible to AI
Misread
Visible but inaccurate
Challenger
AI names competitors first
Incumbent
AI names brand first
Under Scrutiny
Visible but at risk
AI is getting you wrong — claim this profile to correct it
Buyers are hearing the wrong story. Set the record straight.
Claim to correct thisIs this your brand? Claim to correct this — or